PT  - JOURNAL ARTICLE
AU  - Lagana, Stephen M
AU  - Braunstein, Eric D
AU  - Arguelles-Grande, Carolina
AU  - Bhagat, Govind
AU  - Green, Peter H R
AU  - Lebwohl, Benjamin
TI  - Sprue-like histology in patients with abdominal pain taking olmesartan compared with other angiotensin receptor blockers
AID  - 10.1136/jclinpath-2014-202615
DP  - 2015 Jan 01
TA  - Journal of Clinical Pathology
PG  - 29--32
VI  - 68
IP  - 1
4099  - http://jcp.bmj.com/content/68/1/29.short
4100  - http://jcp.bmj.com/content/68/1/29.full
SO  - J Clin Pathol2015 Jan 01; 68
AB  - Aims A severe syndrome characterised by life-threatening diarrhoea and severe sprue-like histology has been described in patients taking the angiotensin receptor blocker (ARB) olmesartan. It is unknown whether there are any histopathological changes in patients without severe diarrhoea exposed to this medication. It is also unknown whether other ARBs cause sprue-like histology. Methods Retrospective cohort study of patients with abdominal pain undergoing upper gastrointestinal endoscopy with duodenal biopsy who were taking ARBs. Patients taking olmesartan (n=20) and a non-olmesartan ARB (n=20) were compared with age and sex-matched controls. Histological features (classic sprue-like and other inflammatory changes) were analysed. Results No single histopathological finding was significantly more common in olmesartan-using patients than controls. However, 10 of 20 olmesartan patients had one or more sprue-like histological features compared with 4 of 20 age-matched and sex-matched controls not taking ARBs (p=0.10). Patients taking ARBs other than olmesartan were not more likely than controls to have one or more of these sprue-like histological features (9/20 vs. 12/20, p=0.34). Conclusions There were no statistically significant differences between olmesartan users with abdominal pain and controls for any single histopathological abnormality. However, there were trends towards significance for individual abnormalities as well as for a composite outcome of sprue-like changes. This raises the possibility that there is a spectrum of histological changes associated with olmesartan use.